IN2006CH01264A - - Google Patents

Info

Publication number
IN2006CH01264A
IN2006CH01264A IN1264CH2006A IN2006CH01264A IN 2006CH01264 A IN2006CH01264 A IN 2006CH01264A IN 1264CH2006 A IN1264CH2006 A IN 1264CH2006A IN 2006CH01264 A IN2006CH01264 A IN 2006CH01264A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Nobukazu Tanaka
Yoshiro Nagai
Hiroshi Kawaguchi
Tadashi Fukami
Terumasa Hosokawa
Original Assignee
Fuji Chem Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Chem Ind Co Ltd filed Critical Fuji Chem Ind Co Ltd
Publication of IN2006CH01264A publication Critical patent/IN2006CH01264A/en
Publication of IN230659B publication Critical patent/IN230659B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1264CH2006 2003-10-15 2004-09-21 IN230659B (enrdf_load_html_response)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003355076 2003-10-15
JP2004236573A JP3841804B2 (ja) 2003-10-15 2004-08-16 口腔内速崩壊性錠剤用の組成物

Publications (2)

Publication Number Publication Date
IN2006CH01264A true IN2006CH01264A (enrdf_load_html_response) 2007-06-29
IN230659B IN230659B (enrdf_load_html_response) 2009-03-27

Family

ID=34380419

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1264CH2006 IN230659B (enrdf_load_html_response) 2003-10-15 2004-09-21

Country Status (7)

Country Link
US (1) US7838033B2 (enrdf_load_html_response)
EP (1) EP1523974B1 (enrdf_load_html_response)
JP (1) JP3841804B2 (enrdf_load_html_response)
KR (1) KR101119850B1 (enrdf_load_html_response)
ES (1) ES2694498T3 (enrdf_load_html_response)
IN (1) IN230659B (enrdf_load_html_response)
WO (1) WO2005037319A1 (enrdf_load_html_response)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
US8647668B2 (en) * 2003-10-15 2014-02-11 Fuji Chemical Industry Co., Ltd. Tablet quickly disintegrating in oral cavity
US8349361B2 (en) * 2003-10-15 2013-01-08 Fuji Chemical Industry Co., Ltd. Composition for rapid disintegrating tablet in oral cavity
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
IL169678A (en) 2005-07-14 2010-11-30 Innova Sa Sweetener compositions
WO2007018192A1 (ja) 2005-08-10 2007-02-15 Shionogi & Co., Ltd. 口腔内崩壊錠剤
JP4965096B2 (ja) * 2005-08-19 2012-07-04 テバ製薬株式会社 圧縮成型製剤
WO2007029376A1 (ja) * 2005-09-02 2007-03-15 Fuji Chemical Industry Co., Ltd. 口腔内速崩壊性錠剤
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
KR101324898B1 (ko) * 2006-03-31 2013-11-04 루비콘 리서치 피브이티. 엘티디. 구강 붕해 정제
BRPI0717570B8 (pt) * 2006-09-26 2021-05-25 Novartis Ag composição farmacêutica sólida adequada para administração oral, seu uso e seu processo de produção
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
WO2008079343A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
UY31411A1 (es) * 2007-10-30 2009-05-29 Composicion orodispersable sin mal olor o mal sabor que comprende acidos grasos poliinsaturados
JP2011513194A (ja) * 2008-02-29 2011-04-28 大塚製薬株式会社 口腔内崩壊錠
JP5572321B2 (ja) * 2008-03-07 2014-08-13 沢井製薬株式会社 被覆微粒子含有口腔内崩壊錠
KR101046789B1 (ko) * 2008-07-16 2011-07-05 동아제약주식회사 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
MX2011005167A (es) * 2008-11-20 2011-05-30 Avantor Performance Mat Inc Excipiente co-procesado basado en fosfato dibasico de calcio, granular, de alta funcionalidad, directamente compresible.
JP4329947B1 (ja) 2009-01-20 2009-09-09 ライオン株式会社 内服用錠剤
EP2397161B1 (en) 2009-02-12 2019-09-25 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and rapidly disintegrating compression-molded material comprising same
JP5806124B2 (ja) 2009-03-09 2015-11-10 エスピーアイ ファーマ,インコーポレイテッド 高度に圧密可能かつ耐久性のある直接圧縮賦形剤および賦形剤系
GB2495563B (en) * 2009-04-28 2014-12-03 Isp Investments Inc Co-processed excipient compositions
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
US8920839B2 (en) 2009-05-20 2014-12-30 Sumitomo Dainippon Pharma Co., Ltd. Dry-coated orally-disintegrating tablet
EP2440210A4 (en) * 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
JP5835875B2 (ja) * 2009-06-29 2015-12-24 富士化学工業株式会社 口腔内速崩壊錠の製造方法
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
US8591955B2 (en) 2009-08-11 2013-11-26 Dainippon Sumitomo Pharma Co., Ltd. Orally rapidly disintegrating tablet that contains two or more types of particles
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
TWI461213B (zh) 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
WO2012085043A2 (en) 2010-12-22 2012-06-28 Basf Se Rapidly disintegrating, solid coated dosage form
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
CN104244930A (zh) * 2012-04-24 2014-12-24 第一三共株式会社 口腔崩解片及其制造方法
US9988542B2 (en) 2012-07-20 2018-06-05 Otsuka Pharmaceutical Co., Ltd. Tablet having dry-ink film on surface thereof, and ink for inkjet printer
FR2999432B1 (fr) * 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage
CN105377303B (zh) * 2013-07-19 2019-04-05 株式会社三和化学研究所 口腔崩解片
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
JP6154019B2 (ja) * 2013-10-07 2017-06-28 富士フイルム株式会社 口腔内崩壊錠
US20160242439A1 (en) 2014-04-04 2016-08-25 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10207004B2 (en) 2014-04-04 2019-02-19 Douxmatok Ltd Method for producing sweetener compositions and sweetener compositions
US10231476B2 (en) 2014-04-04 2019-03-19 Douxmatok Ltd Sweetener compositions and foods, beverages, and consumable products made thereof
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
GEP20217243B (en) 2015-06-18 2021-04-26 Sprl Estetra Orodispersible dosage unit containing an estetrol component
US20160367567A1 (en) 2015-06-18 2016-12-22 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN110237261A (zh) * 2019-07-30 2019-09-17 珠海市东辰制药有限公司 一种复合崩解剂及其制备方法
CN110840855B (zh) * 2019-11-27 2022-04-12 哈尔滨珍宝制药有限公司 依托考昔片及其制备方法
CN115443128A (zh) * 2020-04-24 2022-12-06 阿斯利康(瑞典)有限公司 药物配制品
WO2022210829A1 (ja) * 2021-04-01 2022-10-06 ニプロ株式会社 アビラテロン酢酸エステル含有錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US75437A (en) * 1868-03-10 Improvement in steaw-cutters
DE69331839T2 (de) 1992-01-29 2002-12-12 Takeda Chemical Industries, Ltd. Schnellösliche Tablette und ihre Herstellung
ATE140621T1 (de) * 1993-04-15 1996-08-15 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung
IL110376A (en) 1993-08-02 1998-08-16 Bristol Myers Squibb Co Pharmaceutical compositions containing ifetroban salts and methods for the preparation thereof
KR100386391B1 (ko) 1994-01-31 2003-08-30 야마노우치세이야쿠 가부시키가이샤 구강내용해형정제및이의제조방법
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
AU694655B2 (en) 1995-05-02 1998-07-23 Taisho Pharmaceutical Co., Ltd. Composition for oral administration
JP2003176242A (ja) 1996-07-12 2003-06-24 Dai Ichi Seiyaku Co Ltd 速崩壊性圧縮成型物及びその製造法
JP3961596B2 (ja) 1996-10-15 2007-08-22 富士化学工業株式会社 無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
JPH11302157A (ja) 1998-04-17 1999-11-02 Eisai Co Ltd 口腔内速崩壊性錠剤
JP4711470B2 (ja) 1998-04-24 2011-06-29 富士化学工業株式会社 崩壊補助剤、崩壊補助剤含有口腔内即(速)溶剤用組成物及び口腔内即(速)溶剤の製造方法
US20010023252A1 (en) * 1998-07-02 2001-09-20 Smithkline Beecham Plc Novel compound
JP2000086537A (ja) 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
US7815937B2 (en) 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
FR2785538B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Comprime a delitement rapide perfectionne
WO2000057857A1 (en) 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR20010006835A (ko) * 1999-03-25 2001-01-26 김선진 경구용 속붕해정
WO2000078292A1 (fr) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Preparations solides a desintegration rapide
JP4588818B2 (ja) 1999-09-16 2010-12-01 日本化学機械製造株式会社 錠剤用賦形剤及び錠剤
WO2003030868A1 (en) 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
US6316029B1 (en) 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
JP2002128661A (ja) * 2000-10-20 2002-05-09 Chugai Pharmaceut Co Ltd 速崩壊錠剤の製造方法
JP2002154948A (ja) * 2000-11-22 2002-05-28 Eisai Co Ltd 崩壊性に優れた錠剤
CN1494419A (zh) 2001-03-06 2004-05-05 协和发酵工业株式会社 口腔内快速崩解制剂
EP1416922A1 (en) 2001-07-16 2004-05-12 AstraZeneca AB Pharmaceutical formulation comprising a proton pump inhibitor and antacids
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
AU2003221326A1 (en) * 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity

Also Published As

Publication number Publication date
WO2005037319A1 (ja) 2005-04-28
KR20070018777A (ko) 2007-02-14
US7838033B2 (en) 2010-11-23
US20050106240A1 (en) 2005-05-19
KR101119850B1 (ko) 2012-02-28
JP2005139168A (ja) 2005-06-02
IN230659B (enrdf_load_html_response) 2009-03-27
ES2694498T3 (es) 2018-12-21
JP3841804B2 (ja) 2006-11-08
EP1523974A1 (en) 2005-04-20
EP1523974B1 (en) 2018-08-08

Similar Documents

Publication Publication Date Title
BE2013C075I2 (enrdf_load_html_response)
BE2013C070I2 (enrdf_load_html_response)
BE2013C067I2 (enrdf_load_html_response)
BE2013C038I2 (enrdf_load_html_response)
BE2013C036I2 (enrdf_load_html_response)
BE2011C030I2 (enrdf_load_html_response)
IN2006CH01264A (enrdf_load_html_response)
BE2013C034I2 (enrdf_load_html_response)
BE2012C053I2 (enrdf_load_html_response)
JP2004219779A5 (enrdf_load_html_response)
AU2002329412A1 (enrdf_load_html_response)
AU2002341898A1 (enrdf_load_html_response)
AU2002310561A1 (enrdf_load_html_response)
AU2002311957A1 (enrdf_load_html_response)
AU2002316235A1 (enrdf_load_html_response)
AU2002316511A1 (enrdf_load_html_response)
AU2002318342A1 (enrdf_load_html_response)
AU2002321535A1 (enrdf_load_html_response)
AU2002322913A1 (enrdf_load_html_response)
AU2002324323A1 (enrdf_load_html_response)
AU2002327042A1 (enrdf_load_html_response)
AU2002327736A1 (enrdf_load_html_response)
AU2002255066A1 (enrdf_load_html_response)
AU2002331433A1 (enrdf_load_html_response)
AU2002332887A1 (enrdf_load_html_response)